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Abstract
Background: Tuberculosis (TB) is a major global health problem and remains the leading cause of morbidity and
mortality in developing countries. Routinely used TB diagnostic methods, in most endemic areas, are time-consuming,
often less-sensitive, expensive and inaccessible to most patients. Therefore, there is an urgent need for the development
of early, easy to use and effective diagnosis tools of TB, which can be effectively integrated into resource limited settings,
to anticipate the early treatment and limit further spread of the disease.
Over the last decade, Loop-mediated isothermal amplification (LAMP) assays have become a powerful tool for
rapid diagnosis of infectious diseases because of the simplicity of device requirements. Indeed, LAMP is a simple,
quick and cost effective Isothermal Nucleic Acid Amplification diagnostic test (INAAT) that has the potential to be
used in TB endemic settings of resource-poor countries.
Methods: In the present study, we have developed a simple and rapid TB molecular diagnostic test using a Single-Step
Loop-mediated isothermal DNA amplification (SS-LAMP) method for the detection of Mycobacterium tuberculosis complex
(MTBC) strains, with a simplified sample preparation procedure, eliminating DNA extraction prior to LAMP amplification,
DNA initial denaturation and enzymatic inactivation steps during the amplification process.
To perform our in-house SS-LAMP assay, a set of six specific primers was specifically designed to recognize eight distinct
regions on the MTBC species-specific repetitive insertion sequence 6110 (IS6110). The amplification of the targeted DNA
was carried out under isothermal conditions at 65 °C within 1 h. Our protocol was firstly optimized using 60 of confirmed
MTBC isolates and a recombinant pGEMeasy-IS6110 vector for sensitivity testing. Thereafter, the assay was evaluated on
liquefied sputum specimens collected from 157 Moroccan patients suspected of having TB.
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Results: Our SS-LAMP developed assay was able to detect MTBC DNA directly from liquefied sputum samples without
any prior DNA extraction, denaturation nor the final enzymatic inactivation step. When compared to routinely used
Löwenstein Jensen (LJ) Culture method, our SS-LAMP assay is rapid and showed specificity and sensitivity of 99.14 % and
82.93 % respectively which are within the international standards. In addition, the limit of detection of our assay was
found to be as little as 10 copies of bacterial DNA.
Conclusion: To our knowledge, this is the first study using a single step LAMP (SS-LAMP) procedure as a rapid, easy to
perform and cost effective testing for TB early detection. This innovative assay could be suitable for low-income countries
with restricted health equipment facilities.
Keywords: Tuberculosis, Diagnosis, SS-LAMP, IS6110, MTBC
Background
Caused by bacteria of the Mycobacterium tuberculosis
complex (MTBC), Tuberculosis (TB) is one of the most
deadly infectious diseases worldwide [1]. In 2014, there
were an estimated 9.6 million incident cases of TB globally,
and approximately 1.5 million people died of the disease,
mainly in developing countries [2]. In Morocco, despite
significant efforts to prevent, control and ensure effective
management of TB, its incidence remains high with 28,135
diagnosed new cases including 14,738 of pulmonary new
cases bacteriologically confirmed or clinically diagnosed,
and 13 397 new cases of extra-pulmonary TB forms [2].
Early diagnosis of TB facilitates appropriate treatment
initiation and can limit the spread of this highly conta-
gious disease. Unfortunately, routinely used TB diagnos-
tic methods are time consuming, often less sensitive,
and inaccessible to most of patients in endemic coun-
tries that lack necessary and appropriate financial and
human resources.
In Morocco, as in low and middle income countries, the
World Health Organization (WHO) and the International
Union Against Tuberculosis and Lung Disease (IUATLD)
recommend the diagnosis of TB by sputum smear micros-
copy as a crucial and inevitable step in testing patients
suspected of having pulmonary TB [2, 3]. This technique
seems to be simple, rapid and inexpensive but has the
inconvenience to be less sensitive and requires repeated
patient’s sputum examinations [3].
Otherwise, conventional culture-based methods, because
of their high specificity remain the gold standard test for
the diagnosis of pulmonary TB in Morocco reference
laboratories. Despite its outstanding performance (100
times more sensitive than smear microscopy), the mycobac-
terial culture is notoriously known as time-consuming, dan-
gerous and costly in terms of investment in infrastructure
and equipment [4–6].
When compared to TB routing testing assays, Nucleic
Acid Amplification Tests (NAATs) are most promising
and more relevant in terms of sensitivity and rapidity.
However, expensive infrastructure and advanced technical
skills requirements to conduct these tests are beyond the
scope of most diagnostic facilities offering TB diagnostics
to communities, particularly in high TB-burden countries
where the majority of TB cases occur [7–10].
While most of TB diagnostic NAATs use RT-qPCR
technology, which needs precision, thermal cycler and
sophisticated optical detection systems that add complex-
ity and cost to the instrumentation [11], Loop-mediated
Isothermal Amplification (LAMP) remains an accessible
and cost-effective alternative assay to rapidly detect and
type mycobacteria in pulmonary samples. Indeed, LAMP
requires just constant incubation temperature, and
therefore can be implemented with simplified instru-
mentation [12–16].
In the present study, we established for the first time a
simple and rapid single step LAMP (SS-LAMP) assay
without DNA extraction and denaturation and without
enzyme inactivation steps for the detection of MTBC
strains. We also compared sensitivity, specificity and
applicability of our in-house SS-LAMP assay to LJ culture,
as the Gold Standard routine testing.
Methods
Clinical samples
This study was performed conforming to the ethics
charter of Pasteur Institute (Morocco) that approved the
consent procedure and the proposals of the used protocols.
The protection of patient’s clinical information and preser-
vation of the results confidentiality were guaranteed in the
framework of that charter. According to conventional
WHO guidelines, a total of 60 culture positive isolates
and 157 sputum were collected at Pasteur Institute from
Moroccan patients suspected of having pulmonary TB.
SS-LAMP primers design
A set of SS-LAMP primers complementary to the
nucleotide sequence of IS6110 (GenBank accession
number: X17348) was designed using the online Primer
Explorer V4 software (http://primerexplorer.jp/elamp4.0.0/
index.html; Eiken Chemical Co., Ltd., Tokyo, Japan) accord-
ing to the consensual criteria as described by Notomi and
collaborators [17]. IS6110 specific SS-LAMP primers were
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specifically chosen to recognize eight distinct regions on
the target gene: forward inner primer IS-FIP (F1c-F2), back-
ward inner primer IS-BIP (B1c-B2), and two outer primers,
IS-FOP (F3) and IS-BOP (B3). Two loop primers IS-FLP
and IS-BLP used to accelerate the reaction by providing
more starting sites for the auto-cycling amplification were
designed manually [13, 16]. The directions and details of
the primers sequences are shown in (Fig. 1, Table 1).
These primers were assessed for specificity before use
in LAMP assays by using the Basic Local Alignment
Search Tool (BLAST) with sequences in GenBank of the
National Centre for Biotechnology Information (NCBI).
All the primers were synthesized by Eurofins (Eurofins
MWG Operon, France) and purified using high perform-
ance liquid chromatography (HPLC).
Reference plasmid
To assess the sensitivity of our in-house SS-LAMP assay,
a recombinant plasmid containing the target sequence
of IS6110 (Genbank Accession Number: X173) was
constructed. The Genomic DNA of Mycobacterium
tuberculosis H37Ra (ATCC:25177D-5, USA) was used
to amplify a 202 bp fragment located between the F3
and B3 primer binding site of IS6110 targeted region
by using the IS-F (IS-FOP) and IS-R (IS-BOP) primers.
PCR reactions was performed on Veriti PCR instrument
(Applied Biosystems, USA) under the following cycling
conditions: (i) an initial step at 95 °C for 5 min, (ii) 35 cycles
at 95 °C for 45 s, 58 °C for 45 s and 72 °C for 45 s and (iii) a
final elongation at 72 °C for 7 min. The PCR products were
checked by agarose gel (1 %) electrophoresis, purified with
a Wizard SV gel and PCR clean up system (Promega, USA)
and then cloned into pGEM-T Easy Vector (Promega,
USA). The positive clones obtained after transformation of
competent E. coli DH5-alpha strain (New England Biolabs,
USA) were then checked out by PCR and the resulting
amplicons were identified at the expected size. The
obtained recombinant plasmid was quantified by Nano-
Drop 2000 (Thermo Scientific, USA) and serially diluted to
concentrations of 106, 105, 104, 103, 102, 10 and 1 copy/
reaction. The dilutions were used to evaluate the limit
of detection (LOD) of the SS-LAMP assay and the refer-
ence plasmid as a positive control for further SS-LAMP
reactions.
SS-LAMP reaction
Our in-house SS-LAMP assay was set up in a final volume
of 25 μl based on the original LAMP method described
previously by Notomi et al. [17] with some interesting mod-
ifications allowing us to save time and costs of the reaction.
Indeed, the reaction volume contained 1.6 μM for IS-FIP
and IS-BIP primers, 0.8 μM for loop primers (IS-FLP and
Fig. 1 Location and sequence of primers. a Location and sequence of SS-LAMP target and priming sites. b Annealing position and amplification
orientation of the SS-LAMP primers on the selected 234-bp target sequence of the IS6110
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IS-BLP), 0.2 μM for IS-FOP (F3) and IS-BOP (B3) outer
primers, 2 mM of dNTPs, 0.8 M Betaine (Sigma-Aldrich,
USA), 20 Mm Tris-HCl (pH 8.8), 10 mM KCl, 10 mM
(NH4)2SO4, 9 mM MgSO4, 0.1 % Triton X-100, and 8 U
of Bst 2.0 WarmStart DNA Polymerase (New England
Biolabs, USA), along with 5 μl of DNA template. Further-
more, in order to determine whether LAMP can be
performed under isothermal conditions at all steps, we
attempted to perform the reactions without an initial
heat-denaturation of template DNA and also by removing
the final enzyme inactivation step. Indeed, all the reactions
within a final volume of 25 μl were directly incubated for
a single step of amplification at 65 °C during 60 min.
Moreover and in order to assess the usefulness and
efficacy of different heating devices on SS-LAMP ampli-
fication, a thermal cycler, a water bath, a dry thermal
block with a 0.2-mL PCR tube holder and finally a Lab-
on-card prototype (Fig. 2), were used to maintain the
temperature required for the amplification reaction. To
measure constantly the water bath and the dry thermal
block temperatures during the experiments, a calibrated
thermometer was used. However, for the thermal cycler
(calibrated every six months) and the in-house Lab-on-
card device, an integrated electronic circuit allowed a
real-time verification of the heating bloc and the Peltier
System temperatures respectively.
A negative control (DEPC-treated water) and a positive
control (Genomic DNA of M. tuberculosis H37Ra refer-
ence strain) (ATCC, Manassas, VA, USA) were used for
every run.
In our present study, the results were visualized by add-
ing 1 μl of 1:10 SYBR Green I stock dilution ($US 0.08/re-
action) (Life Technologies, USA) and then, observed under
both visible light and UV light. A yellowish green colour
(under natural light conditions) indicated a positive reac-
tion, while orange indicated a negative reaction. SS-LAMP
products were then subjected to 2 % agarose gel electro-
phoresis, stained by EZ-Vision® DNA Dye (Amresco, USA),
and visualized under UV light. All the SS-LAMP reactions
have been performed in triplicate to assess to reprodu-
cibility of the assay.
Determination of the primers specificity and limit of
detection of the SS-LAMP assay
To verify their specificity for the detection of MTBC
IS6110 sequence, our selected primers were tested using
DNA from 60 MTBC positive isolates provided by the
Pasteur Institute of Morocco. These MTBC isolates were
previously confirmed by conventional PCR and LJ culture
method. SS-LAMP primers have been also tested on some
MTBC strains DNA (M. tuberculosis H37Rv, ATCC
25618D-2; M. tuberculosis H37Ra, ATCC 25177D-5; M.
bovis, ATCC-BAA-935D-2) and non-MTBC strains
DNA (M. avium, ATCC-BAA-968D-5; M. kansasii, ATCC
12478; M. intracellulare, ATCC 35769; M. abscessus, ATCC
19977D-5; M. gordonae, ATCC 14470D-5; M. smegmatis,
ATCC 700084D-5; Escherichia coli, ATCC 8739;
Pseudomonas aeruginosa, ATCC 9027; Staphylococcus
aureus, ATCC 6538; Candida albicans, ATCC 10231;
Aspergillus niger, ATCC 16888).
To explore the sensitivity, the limit of detection (LOD)
of our SS-LAMP assay was assessed by serial dilutions
of the purified reference plasmid (pGEMeasy-IS6110) with
DEPC-treated water to obtain a standard series from 106
Table 1 Nucleotide sequences of the SS-LAMP primers targeting
the IS6110 sequence of MTBC strains





F3 (FOP) 761-778 TCTCGTCCAGCGCCGCTT
B3 (BOP) 945-962 GCGGGTCCAGATGGCTTG
FLP 813-831 TCGACACATAGGTGAGGTC
BLP 901-918 TCGCTTCCACGATGGCCA
Fig. 2 SS-LAMP on a Lab-on-card device. Prototype of our in house
Lab-on-card device (LOC) and a visual detection of SS-LAMP reaction
performed on this prototype
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to 1 copy per reaction. The serial dilutions were subjected
to amplification reaction conditions exactly as previously
described. All the reactions were performed in 3 repli-
cates. Escherichia coli bacteria DNA and DEPC-treated
water were used as negative controls.
SS-LAMP assay on clinical sputum samples
Once optimized, the SS-LAMP assay was performed on
clinical sputum specimens to evaluate the feasibility and
accuracy of the assay when compared to culture isolate
results. For that purpose, 157 sputum samples from TB
suspected patients, collected by the Pasteur Institute
were liquefied and decontaminated using 4 % NaOH. A
part of the liquefied sputum was used for culture in LJ
solid medium following the standard protocol and a
second part directly utilized for SS-LAMP evaluation. In
the present study, SS-LAMP reactions were performed
using 5 μl of liquefied/decontaminated sputum without
any prior heat treatment, DNA extraction procedure or
kits. To control any eventual cross-contamination, one
negative control was also used for every run.
Statistical analysis
Sensitivity and specificity [18] as well as the positive and
negative likelihood ratios [19] of the SS-LAMP assay were
calculated in comparison with the standard LJ culture
results.
Results
Optimization of the SS-LAMP assay using different
amplification devices
In the present study, 3 sets of primers, specific to MTBC
IS6110 sequence, were used for the SS-LAMP amplifica-
tion. The set that showed the highest amplification per-
formance was selected for further analysis (Fig. 1, Table 1).
To optimize the SS-LAMP reaction temperature, we
conducted the assay under two different temperature
conditions (63 °C and 65 °C). Given the important amount
of DNA amplicons produced on both thermal condi-
tions and based on the optimal temperature for Bst 2.0
WarmStart DNA Polymerase activity, an incubation
temperature of 65 °C was used for all tests in this study.
In order to determine whether our SS-LAMP assay can
be performed in a single step procedure, we amplified the
IS6110 target sequence directly from the liquefied sputum
samples. Indeed, reactions mixtures were carried within a
final volume of 25 μl without any prior DNA extraction,
initial DNA heat denaturation nor enzymatic inactivation.
DNA amplification was completed within one hour at
isothermal condition (65 °C in a water bath). The obtained
products of the SS-LAMP reactions were then detected
by SYBR Green nucleic acid stain. Positive samples chan-
ged colour from orange to green while negatives remained
orange (Fig. 3a). The products were also viewed on a 2 %
agarose gel and showed ladder-like patterns (Fig. 3b). The
same results have been obtained when the SS-LAMP
amplification was performed on other heating devices,
rather than the water bath, such as a thermal cycler and a
dry thermal block (data not shown).
Presently, we are developing an innovative temperature
controlled Lab-on-card prototype based on our SS-LAMP
method, described in the present study (Fig. 2). This port-
able battery powered device, conceived to be used in re-
mote low-resource settings without electricity, showed
encouraging preliminary data, similar to the ones obtained
using water bath (Fig. 3a). Thus, MTBC positive samples
turned to green under UV excitation whereas the negative
control remained orange.
Specificity of the SS-LAMP assay primers
First of all, we examined the specificity of our selected
SS-LAMP primers using genomic DNA from 60 previ-
ously confirmed MTBC isolates by Gold Standard cul-
ture and conventional PCR. Efficient DNA amplification
was assessed using M. tuberculosis complex including M.
tuberculosis H37Rv, M. tuberculosis H37Ra and M. bovis.
The results showed that no DNA amplifications were
observed when using non-MTBC bacterial species (data
not shown). These results confirm that our selected SS-
LAMP primers are highly specific to MTBC strains.
Limit of detection of the SS-LAMP assay
The sensitivity of the SS-LAMP assay for MTBC strains
was assessed by the limit of detection (LOD) method
using serial 10-fold dilutions of reference plasmid
pGEMeasy-IS6110, as previously described. The results
indicated that the LOD of the SS-LAMP assay was 10
copies of IS6110 sequence (Fig. 4). This SS-LAMP LOD
was comparable to the one of RT-qPCR, performed in our
previous studies [20, 21] on reference plasmid pGEMeasy-
IS6110 (Fig. 4).
Clinical comparative study between SS-LAMP and
Löwenstein-Jensen culture method
The clinical results of a total of 157 sputum samples
were determined using both the SS-LAMP assay and the
LJ culture method. Briefly, thirty four patient sputum
samples used in this study were positive in LJ culture
and SS-LAMP method and 115 specimens were negative
in LJ culture as well as in SS-LAMP. Seven sputum that
were tested MTBC negative using SS-LAMP, grew on
the LJ solid medium. Finally, for one sputum sample, the
SS-LAMP was positive and the LJ culture negative.
The analysis of these results using reference methods
[18, 19] demonstrated that SS-LAMP showed good sen-
sitivity (82.3 %) and specificity (99.14 %) for the used
clinical sputum specimens compared to culture (n = 157),
as shown in Table 2. Accordantly, the positive likelihood
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ratio and the negative likelihood ratio were 96.20 and 0.17
respectively (Table 2). Hence, these results indicate that our
SS-LAMP assay described here could be efficiently
applied for TB diagnosis by testing directly patient spu-
tum samples.
Discussion
Loop-mediated isothermal amplification (LAMP) is an
innovative method that has been used recently at the basis
of the development of a number of diagnostic methods to
detect several infectious diseases including TB.
The present study aims to develop and evaluate a novel
in-house LAMP-based procedure, so called single step
LAMP (SS-LAMP), for the detection of M. tuberculosis
complex strains in clinical sputum samples. For that pur-
pose, we explored whether we can perform the classical
LAMP method in one uninterrupted process, with no need
to any previous DNA extraction, denaturation nor final en-
zymatic inactivation step. Hence, when compared to clas-
sical LAMP, the SS-LAMP is time and cost-effective and
could be a suitable alternative method for TB diagnosis in
low income developing countries.
Before the optimization of our SS-LAMP assay, we
first demonstrated the high specificity of our selected
primer set, using 60 separate cultures isolates obtained
from the sputum of TB positive patients. Secondly, a limit
of detection (LOD) of 10 copies per reaction showed the
high sensitivity of our SS-LAMP assay which was equal to
the LOD of the highly sensitive RT-qPCR method (Fig. 4).
To set-up the optimization of our SS-LAMP procedure, a
WarmStart Bst DNA Polymerase, active relatively at high
isothermal amplification temperature, reducing non-
specific priming, was used. The SS-LAMP assay was
optimized in a way allowing sensitive detection of all
MTBC strains within a 60 min reaction, in culture iso-
lates or sputum samples.
The SS-LAMP starts with the direct mixing, in a PCR
tube, of a small volume of liquefied and decontaminated
patient’s sputum added to the reaction master mix. The lat-
ter is then incubated directly at 65 °C during one hour. The
Fig. 3 Detection of SS-LAMP. a Visual Detection of SS-LAMP products using inspection of the color change in 1000 X SYBR Green I by the naked
eye under visible and UV lights respectively: Samples that turned yellowish green were considered positive, while those remained orange were
assumed to be negative. Tube 1 to 6: SS-LAMP products of Mycobacterium tuberculosis extracted genomic DNA. NC: Negative Control. PC: Positive
Control (M. tuberculosis H37Ra genomic DNA). b Lanes 1 to 6: Gel electrophoresis of SS-LAMP products of Mycobacterium tuberculosis genomic
DNA. NC: Negative Control. PC: Positive Control (M. tuberculosis H37Ra genomic DNA). M: 1 kb Ladder
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only equipment needed for this assay is a water bath or a
heat block that furnishes a constant temperature of 65 °C.
A reference plasmid, pGEMeasy-IS6110, was constructed
to be included into the SS-LAMP assay as a positive con-
trol instead of using a genomic DNA of Mycobacterium
references strains whose the preparation is expensive and
time consuming.
To assess the correlation between the results obtained
from the SS-LAMP and the Gold Standard LJ culture
method, a total of 157 collected patient’s sputum were
Fig. 4 Limit of detection (LOD) of SS-LAMP. a Limit of Detection (LOD) of the SS-LAMP assay. Tubes 1–7 showed the color change from original
orange color to bright green. The tubes contained 106, 105, 104, 103, 102, 10 and 1 copy/reaction of purified reference plasmid (pGEMeasy-IS6110),
respectively. NC: Negative control. b Limit of Detection (LOD) of RT-qPCR reaction: Amplification plot shows the normalized fluorescent signal
(Rn) versus cycle number. The reaction wells contained duplicates of 106, 105, 104, 103, 102, 10 and 1 copy/reaction of purified reference plasmid
(pGEMeasy-IS6110), respectively
Table 2 Efficacy of SS-LAMP assay compared to gold standard LJ culture







LAMP (n = 157) 82.93 99.14 0.17 96.20
Positive 34 1
Negative 7 115
%95CI = 67.94 - 92.85 95.29 – 99.98 0.09 - 0.34 13.60 - 680.51
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liquefied and decontaminated prior to both culture and
SS-LAMP evaluation. After LJ medium inoculation, the
small remaining volume of decontaminated sputum was
then used for SS-LAMP testing. The clinical comparison
of the results was performed using the analytical specifi-
city and sensitivity methods as described in the literature
[18, 19]. As shown in table 2, when compared to LJ
culture, our SS-LAMP showed high specificity (99.14 %)
and sensitivity (82.93 %). These results are much higher
to the one described in the literature for the MTBC
detection by smear microscopy which showed up to 60 %
maximum sensitivity when compared LJ culture [22]. Inter-
estingly, the specificity and sensitivity of our SS-LAMP
when compared to LJ culture are within the range of those
reported earlier using the original LAMP method per-
formed on extracted DNA samples and involving DNA
denaturation and enzyme inactivation steps [23]. In fact, a
LAMP assay, performed on lysed samples and in 2 h ampli-
fication reaction showed a sensitivity and specificity values
of 79.5 % and 93.8 % respectively, which are remarkably
much lower than the obtained values of the present study
[23]. The unique specimen that was negative on LJ culture
and LAMP positive (Table 2) may suggest that SS-LAMP is
probably highly sensitive in the detection of a small number
of tubercle bacilli released from hidden foci of this patient
sputum. SS-LAMP might also detect MTBC circulating
DNA from non-viable lysed bacteria and hence non-
culturable on LJ medium.
Otherwise, seven specimens that were positive on LJ
culture were SS-LAMP negative (Table 2). This discordance
could be due to false positive cultures of Mycobacter-
ium tuberculosis that resulted from laboratory cross-
contamination. The presumed false positive cultures in
our study represent a rate of 4.45 % (7 of 157) which is
similar to the rates shown in previous studies of M. tu-
berculosis cultures [24–26]. In fact, in most population-
based studies, rates of false positive cultures has been
reported to be ranging from 2.2 – 10.5 % [27]. Indeed,
many causes can lead to false-positive cultures such as
clerical errors, contaminated clinical equipment, laboratory
cross-contamination, contamination from species identifi-
cation procedures [26] or a faulty exhaust hood [28]. Fur-
thermore, the results discrepancies between LJ culture and
SS-LAMP can also be caused by the presence into the pa-
tient’s specimens of nontuberculous mycobacteria that can
easily grow on LJ culture medium [29]. Otherwise, MTBC
strains lacking the IS6110 insertion sequence might explain
the seven missed samples [30]. In fact, these strains may
escape detection by our SS-LAMP assay that specifically
target the IS6110 sequence. Unfortunately, we do not have
yet sufficient data on the prevalence of these MTBC strains
in Morocco and in neighboring countries. To date only a
single study has evaluated the frequency of M. tuberculosis
strains Lacking IS6110 among 102 sputa isolated from
Moroccan patients and have shown that only twoM. tuber-
culosis strains were lacking the insertion sequence [31]. In
all circumstances, to overcome this limitation, including in
our assay a complementary MTBC-specific gene such as
MPB64 will allow certainly to cover the whole MTBC
strains spectrum.
Overall, it is actually well known that the most miss-
advantageous troubleshooting of the LAMP methodology
consists of getting false positive result which is, basically,
due to aerosol cross-contamination between tubes when
the dye was added to the reaction [32, 33]. These studies
have demonstrated that the high risk of contamination
with LAMP is due, essentially to the exposure of tubes to
the high temperature during enzyme inactivation. This
final step was removed from our patented SS-LAMP pro-
cedure [20, 21] that has proven its undeniable capacity to
be efficient, specific and reproducible in the detection of
the target under a constant temperature, which allows
overcoming the possible cross-contamination that may re-
sult from the enzymatic inactivation of previous reactions.
In addition, in our study, we proved that the SS-LAMP
assay can keep the noteworthy features to include just a
heat block, a simple water bath or a cost effective Lab-on-
card device instead of a costly thermal cycler, gel electro-
phoresis system and UV trans-illuminator. Furthermore,
our SS-LAMP assay is performed under isothermal condi-
tions at a constant temperature of 65 °C, circumventing
the time length involved in thermal changes of conven-
tional amplification methods.
Conclusion
In conclusion, the SS-LAMP developed in this study pro-
vides a number of advantages over microscopy and culture
including superior sensitivity and significantly less operating
time. Furthermore, the SS-LAMP constitutes an easily han-
dled, one step diagnostic tool for rapid, sensitive, specific
and accurate identification of M. tuberculosis complex, in
both culture isolates and sputum specimens. Thanks to its
simplicity, robustness, easy use without necessary sophisti-
cated equipment and its feature to be performed in simple
laboratories, small-scale hospitals and primary care facilities
in developing countries, the SS-LAMP promotes to be suit-
able for diagnostic of TB as a point of care (POC) assay.
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